Sign in

CIK 0001137883

  • Non-accelerated filer
  • Smaller reporting company

BRAINSTORM CELL THERAPEUTICS INC.

Sign in to watch
Ticker
BCLI
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
207273918
Phone
+1 201-488-0460
Business address
1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
Former names
BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
  1. 4 Open-market buy Member of 10% owner group bought 6,700 shares at an average $4.14 ($27,738)
  2. 4 Open-market buy Member of 10% owner group bought 11,000 shares at an average $4.17 ($45,847)
  3. 4 Open-market buy Chief Executive Officer bought 800 shares at $3.84 ($3,072)
  4. 4 Open-market buy Chief Executive Officer bought 18,000 shares at an average $0.28 ($5,126)
  5. 4 Grant or award Director acquired 130,000 shares (grant or award)
  6. 4 Grant or award Director acquired 130,000 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy Member of 10% owner group bought 130,000 shares at $0.29 ($37,700)
  12. 4 Open-market buy Member of 10% owner group bought 150,000 shares at $0.35 ($52,500)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market buy Member of 10% owner group bought 939,600 shares at $0.30 ($281,880)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Grant or award Director acquired 130,000 shares (grant or award)

Page 10 of 17 · 329 filings